![]() |
同义名 : | RG7314 |
CAS号 : | 1228088-30-9 | |
货号 : | A718871 | |
分子式 : | C22H24ClN5O | |
纯度 : | 99%+ | |
分子量 : | 409.91 | |
MDL号 : | MFCD31706224 | |
存储条件: |
Pure form Sealed in dry, 2-8°C In solvent -20°C:3-6个月-80°C:12个月 |
|
溶解度 : | - | |
动物实验配方: |
生物活性 | |||
---|---|---|---|
描述 | Balovaptan , also known as RG7314, is an orally potent, selective, blood-brain barrier-crossing vasopressin 1a (hV1a) receptor antagonist with Ki values of 1 and 39 nM for human and mouse (hV1a, mV1a) receptors, respectively, and can be used in autism research[1]. |
临床研究 | |||||
---|---|---|---|---|---|
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
NCT02901431 | Autism Spectrum Disorder | Phase 2 | Recruiting | April 18, 2019 | - |
NCT03586726 | Healthy Volunteers | Phase 1 | Active, not recruiting | November 15, 2018 | Netherlands ... 展开 >> Pra International Group B.V Groningen, Netherlands, 9728 NZ 收起 << |
NCT03504917 | Autism Spectrum Disorder | Phase 3 | Recruiting | March 31, 2023 | - |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
2.44mL 0.49mL 0.24mL |
12.20mL 2.44mL 1.22mL |
24.40mL 4.88mL 2.44mL |